Insiders who reported open-market trades in the last 12 months at the companies Jurgi Camblong files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Zhenyu Xu - $761K in SOPH purchases and sales in the last 12 months
Philippe Menu - $478K in SOPH purchases and sales in the last 12 months
Abhimanyu Verma - $266K in SOPH purchases and sales in the last 12 months
Ross Muken - $225K in SOPH purchases and sales in the last 12 months
Manuela Valente - $159K in SOPH purchases and sales in the last 12 months
Well Daan van - $142K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jurgi Camblong is a corporate insider, tracked as Executive Chairman, Director of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 20 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jurgi Camblong submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jurgi Camblong been buying or selling stock?
Recorded transactions: 0 open-market purchases and 31 open-market sales ($2.65M) across all tracked filings.
Jurgi Camblong is Executive Chairman, Director of SOPHiA GENETICS SA (SOPH). 20 SEC Form 4 filings on record, most recently on 7 October 2026. Most recent open-market trade: sold $327K of SOPH on 7 October 2026. Lifetime open-market sales: $2.65M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Jurgi Camblong.
InsiderAlpha's records for Jurgi Camblong go back to 2026: 20 primary Form 4 filings, an average of 20.0 per year. 39 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
